BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
6/11/2024 2:35:35 PM | Browse: 42 | Download: 339
 |
Received |
|
2024-01-19 07:40 |
 |
Peer-Review Started |
|
2024-01-19 07:40 |
 |
To Make the First Decision |
|
|
 |
Return for Revision |
|
2024-02-05 07:58 |
 |
Revised |
|
2024-03-05 16:18 |
 |
Second Decision |
|
2024-04-10 03:04 |
 |
Accepted by Journal Editor-in-Chief |
|
|
 |
Accepted by Executive Editor-in-Chief |
|
2024-04-17 06:57 |
 |
Articles in Press |
|
2024-04-17 06:57 |
 |
Publication Fee Transferred |
|
|
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
2024-05-23 05:01 |
 |
Publish the Manuscript Online |
|
2024-06-11 14:35 |
ISSN |
1948-9358 (online) |
Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
Copyright |
© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
Website |
http://www.wjgnet.com |
Category |
Ophthalmology |
Manuscript Type |
Retrospective Study |
Article Title |
Efficacy of recombinant human epidermal growth factor plus sodium hyaluronate eye drops in diabetic dry eye post-cataract surgery
|
Manuscript Source |
Unsolicited Manuscript |
All Author List |
Jun-Ling Li, Jin Zhao, Zhen-Feng Guo, Chang Xiao and Xuan Liu |
ORCID |
|
Funding Agency and Grant Number |
Funding Agency |
Grant Number |
Tianjin Health Research Project |
TJWJ2023MS062 |
|
Corresponding Author |
Xuan Liu, MM, Doctor, Doctor, Department of Ophthalmology, Xianyang First People's Hospital, No. 10 Biyuan Road, Qindu District, Xianyang 712000, Shaanxi Province, China. lx641131366@126.com |
Key Words |
Recombinant human epidermal growth factor; Sodium hyaluronate eye drops; Diabetic patients; Dry eye syndrome after cataract surgery; Therapeutic efficacy |
Core Tip |
Cataracts are a common clinical blinding eye disease with a high incidence among the older population. Phacoemulsification followed by intraocular lens implantation is currently the mainstream surgical method for treating cataracts and restoring visual function. However, patients with diabetes often have a higher incidence of dry eye syndrome (DES) after cataract surgery compared with nondiabetic patients because of factors such as less basic tear secretion and poor tear film stability, which seriously affect the patient’s quality of life. Therefore, the effective improvement of DES after cataract surgery in these patients is of great clinical significance. Considering the specific clinical application scenarios, the effect of recombinant human epidermal growth factor combined with sodium hyaluronate eye drops on DES in patients with diabetes after cataract surgery warrants exploration. |
Publish Date |
2024-06-11 14:35 |
Citation |
<p>Li JL, Zhao J, Guo ZF, Xiao C, Liu X. Efficacy of recombinant human epidermal growth factor plus sodium hyaluronate eye drops in diabetic dry eye post-cataract surgery. <i>World J Diabetes</i> 2024; 15(6): 1234-1241</p> |
URL |
https://www.wjgnet.com/1948-9358/full/v15/i6/1234.htm |
DOI |
https://dx.doi.org/10.4239/wjd.v15.i6.1234 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345